Table 1 Underlying comorbidities and clinical presentations of included patients
From: Initial viral cycle threshold values in patients with COVID-19 and their clinical significance
Characteristics | Frequency | Percentage |
|---|---|---|
Diabetes mellitus | 95 | 47.0 |
Cardiac disease | 43 | 21.3 |
Lung disease | 23 | 11.4 |
COPD | 3 | 1.5 |
Heart failure | 11 | 5.4 |
ESRD | 13 | 6.4 |
Hemodialysis | 8 | 4.0 |
Cancer | 3 | 1.5 |
Fever | 148 | 73.3 |
Shivering | 16 | 7.9 |
Shortness of breath | 88 | 43.6 |
Chest pain | 20 | 9.9 |
Wheezes | 6 | 3.0 |
Cough | 141 | 69.8 |
Hemoptysis | 5 | 2.5 |
Sore throat | 29 | 14.4 |
Headache | 36 | 17.8 |
Myalgia | 65 | 32.2 |
Vomiting | 29 | 14.4 |
Diarrhea | 34 | 16.8 |
Tachypnea | 8 | 4.0 |
Respiratory distress | 26 | 12.9 |
Oxygen saturation | 100 | 49.5 |
Admitted to ICU | 70 | 34.7 |
Single lobar infiltrate | 20 | 15.0 |
Multi-lobar infiltrate | 125 | 71.4 |